Cell Therapy Centre HUKM (UKM Medical Centre)
Address: 12th Floor, Clinical Block, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia.
Cell Therapy Center is one of the Center of Excellence in UKM Medical Centre (UKMMC) which provides cell-based therapy including hematopoietic stem cells, lymphocytes, dendritic cells, mesenchymal stem cells and mononuclear cells to patients with blood cancers, bone marrow diseases and degenerative diseases. The Cell Therapy Centre has the aspiration to be among the world leaders in research and development (R&D) of cancer immunotherapy and regenerative medicine.
Cell Therapy Centre (CTC), also known as Pusat Terapi Sel (PTS) was established in 1999 with the aim to deliver high quality care using the latest technology and novel treatment modalities to patients with blood cancers and bone marrow failure conditions locally and overseas. Thus far, CTC has conducted more than 200 cases of autologous, allogeneic haematopoietic stem cell transplantations. Our main niche initially consists of hematopoietic stem cell transplantation and cancer Immunotherapy. More recrently, CTC has also widened its scope by developing cell-based therapy to patients with degenerative diseases. PTS works closely with clinical investigators, other research institutes, and various healthcare industries to promote, attract, and facilitate the use of a wide variety of cell-based products. This move is in line with intensive stem cell research and development activities and the increasing market demand for cell-based product.
To ensure that objectives are met, CTC is also actively involved in establishing partnerships with other well established health organizations or institutions.
The services provided in PTS consist of 4 main components
- Hematopoietic Stem Cell Transplantation
- Regenerative medicine
- Cancer immunotherapy
- Novel Drugs Treatment
- Clinical trial service
- Stem cell collection and storing
The center has excellent infrastructure and manpower to support R&D activities related to fundamental and applied research using various types cell-based products. In 2008, CTC has successfully set up a cGMP compliant laboratory in UKMMC in collaboration with InnoBio Diagnostics Sdn. Bhd. This cGMP PTS-IBD Laboratory lab is equipped with a wide range of instruments/tools and managed by a fully trained team. In 2009, the laboratory began its operations in translational research and since then has been producing clinical grade cellular products for regenerative medicine and cancer immunotherapy.PTS is committed to conduct a high quality clinical trial service by providing a dedicated and qualified personnel consisting of GCP (good clinical practice) certified consultant hematologists and cell transplant physician, clinicians, clinical trial coordinators, clinical research nurses, research officers, and scientific officers.
Since 2011, CTC has successfully conducted many clinical trials in close collaboration with private and public medical institutions abroad and locally.
In the next 3 to 5 years, CTC hope to extend the indication and scope of cell-based immunotherapy to patients with solid cancers and pediatric populations. CTC hope that more patients will have access to and benefit from novel and innovative therapy by participating in internationally funded clinical trials. The future and success of cell based therapy for cancers and degenerative diseases in Malaysia require continuing positive input from the regulators, administrators, physicians and scientists.
Category / Check out more related articles: Stem Cell